This report contains market size and forecasts of Statin in China, including the following market information:
China Statin Market Revenue, 2016-2021, 2022-2027, ($ millions)
China Statin Market Sales, 2016-2021, 2022-2027, (K MT)
China top five Statin companies in 2020 (%)
The global Statin market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.
The China Statin market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Statin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Statin Market,

By Type

, 2016-2021, 2022-2027 ($ Millions) & (K MT)
China Statin Market Segment Percentages,

By Type

, 2020 (%)
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others

China Statin Market,

By Application

, 2016-2021, 2022-2027 ($ Millions) & (K MT)
China Statin Market Segment Percentages,

By Application

, 2020 (%)
Cardiovascular Disorders
Obesity
Inflammatory Disorders
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Statin revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Statin revenues share in China market, 2020 (%)
Key companies Statin sales in China market, 2016-2021 (Estimated), (K MT)
Key companies Statin sales share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Merck
Pfizer
Amgen
Aurobindo Pharma